Supplement manufacturer for Cyprus brands

Cyprus is a 1 million-person market with Nicosia as its administrative capital and Nicosia as its largest commercial city. Key commercial cities include Nicosia, Limassol, Larnaca, Paphos. The working language for label artwork, regulatory submission and retail packaging is Greek and English (bilingual labelling is the practical norm). Retail distribution flows through Pharmacy network, Alphamega and AlfaMega Hypermarkets, and a bilingual DTC sector. On the supplement industry signal: Limassol shipping registry + tourism channel + Greek-language artwork compatibility. For brand owners briefing DAT Supply, Cyprus is positioned as a regulated EU food-supplement market: artwork is produced in Greek and English (bilingual labelling is the practical norm), the food business operator (typically the brand owner) carries label responsibility under the EU Reg. 1169/2011 framework, and the notification is filed with the country's competent authority (see the Regulatory framework section). DAT coordinates manufacturing, documentation and shipping under a single project so the brand owner can focus on demand generation, retail placement and the post-launch reorder cycle. The country's neighbours and natural cross-launch pairs for a single artwork project are listed under the internal links below.

Dietary supplements in Cyprus are regulated as a category of food. The framework rests on EU Directive 2002/46/EC (food supplements), EU Reg. 1169/2011 (food information to consumers) and EU Reg. 1924/2006 / 432/2012 (nutrition and health claims), transposed nationally as EU Reg. 1924/2006 and 1169/2011, plus the Cypriot Food Council laws on food supplements and the Cyprus Ministry of Health notification. Notification authority and route: Cyprus Ministry of Health. MoH notification. The brand owner is the food business operator and carries label responsibility — DAT supplies the documentation pack but does not file on the brand owner's behalf. Label-language requirement: Greek and English bilingual artwork is the practical requirement. Allergen labelling: EU FIC 1169/2011 allergens in both Greek and English with bold emphasis. Novel ingredients: the EU novel food catalogue applies. Claim wording is the most-reviewed surface of the artwork pack. Permitted health claims are drawn from the EU 432/2012 register and any on-hold claims awaiting EFSA opinion; structure-function copy that does not assert disease prevention, treatment or cure is reviewed against the boundary set by Article 7 of Reg. 1169/2011 and the national authority's published guidance. Common rejection patterns: (i) implied disease-treatment phrasing on energy, sleep or stress SKUs, (ii) un-permitted comparative claims against medicines, (iii) using authorised-claim wording on products that do not meet the conditions of use, and (iv) translated claim wording that drifts from the authorised phrasing. DAT's artwork gate cross-references every claim on the pack against the authorised register or the national authority's borderline guidance before the brand owner files. Distinctive Cyprus signal: MoH notification is operator-led; bilingual labelling is the practical norm and shapes pack layout. Certification panel commonly seen on Cyprus pack: V-Label, EU organic leaf, kosher / halal where the brief requires it. Where certification is desired the brand owner provides the certificate and DAT confirms compliance against the certifier's scheme during the documentation pack assembly. Retailer-specific documentation expectations: pharmacy, drugstore and grocery buyers commonly request the technical dossier (formulation specification, raw-material specifications, microbiological release criteria, stability summary, allergen statement, country-of-origin declaration, certificate of GMP-aligned manufacturing) before listing a new SKU. DAT supplies the dossier as a single packaged set so the brand owner can present a complete file at the listing meeting. Post-launch obligations: the food business operator records and investigates any adverse events through the national vigilance route, maintains the technical file for the legal retention period (commonly five years from last batch shelf life), and keeps the artwork in step with any future authoritative re-interpretation of claim wording on the authorised register. DAT supports the brand owner through batch-by-batch documentation and an artwork variant track when the register changes.

Notification authority: Cyprus Ministry of Health